These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.
    Author: Murdoch DR, Reller LB.
    Journal: Antimicrob Agents Chemother; 2001 Dec; 45(12):3623-4. PubMed ID: 11709354.
    Abstract:
    Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.
    [Abstract] [Full Text] [Related] [New Search]